0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Multicancer Detection Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-27H14449
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Multicancer Detection Market Research Report 2023
BUY CHAPTERS

Global Multicancer Detection Market Research Report 2025

Code: QYRE-Auto-27H14449
Report
May 2025
Pages:88
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Multicancer Detection Market

The global market for Multicancer Detection was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Multicancer Detection refers to the ability to detect various types of cancer within the human body. It typically involves diagnostic methods or technologies that can identify cancerous cells or biomarkers associated with different cancer types simultaneously or in a single test.
The development of liquid biopsy tests for multicancer detection is gaining momentum, allowing for early cancer detection through blood tests. Advancements in liquid biopsy technologies and the integration of AI for data analysis are notable trends.
This report aims to provide a comprehensive presentation of the global market for Multicancer Detection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Multicancer Detection.
The Multicancer Detection market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Multicancer Detection market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Multicancer Detection companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Multicancer Detection Market Report

Report Metric Details
Report Name Multicancer Detection Market
Segment by Type
  • Laboratory Developed Tests (LDTs)
  • In-Vitro Diagnostics (IVDs)
Segment by Application
  • Hospital
  • Clinic
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Agilent Technologies, Inc., Atara Biotherapeutics, Inc., Burning Rock DX, Danaher Corporation, Exact Sciences Corporation, Hoffmann-La Roche Ltd, Fulgent Genetics., Genecast Biotechnology Co., Ltd, Guardant Health, Inc., Illumina, Inc., Konica Minolta, Inc., Laboratory Corporation of America Holdings., Myriad Genetics, Inc., Tempus, Thermo Fisher Scientific Inc.
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Multicancer Detection company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Multicancer Detection Market report?

Ans: The main players in the Multicancer Detection Market are Agilent Technologies, Inc., Atara Biotherapeutics, Inc., Burning Rock DX, Danaher Corporation, Exact Sciences Corporation, Hoffmann-La Roche Ltd, Fulgent Genetics., Genecast Biotechnology Co., Ltd, Guardant Health, Inc., Illumina, Inc., Konica Minolta, Inc., Laboratory Corporation of America Holdings., Myriad Genetics, Inc., Tempus, Thermo Fisher Scientific Inc.

What are the Application segmentation covered in the Multicancer Detection Market report?

Ans: The Applications covered in the Multicancer Detection Market report are Hospital, Clinic

What are the Type segmentation covered in the Multicancer Detection Market report?

Ans: The Types covered in the Multicancer Detection Market report are Laboratory Developed Tests (LDTs), In-Vitro Diagnostics (IVDs)

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Multicancer Detection Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Laboratory Developed Tests (LDTs)
1.2.3 In-Vitro Diagnostics (IVDs)
1.3 Market by Application
1.3.1 Global Multicancer Detection Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Clinic
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Multicancer Detection Market Perspective (2020-2031)
2.2 Global Multicancer Detection Growth Trends by Region
2.2.1 Global Multicancer Detection Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Multicancer Detection Historic Market Size by Region (2020-2025)
2.2.3 Multicancer Detection Forecasted Market Size by Region (2026-2031)
2.3 Multicancer Detection Market Dynamics
2.3.1 Multicancer Detection Industry Trends
2.3.2 Multicancer Detection Market Drivers
2.3.3 Multicancer Detection Market Challenges
2.3.4 Multicancer Detection Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Multicancer Detection Players by Revenue
3.1.1 Global Top Multicancer Detection Players by Revenue (2020-2025)
3.1.2 Global Multicancer Detection Revenue Market Share by Players (2020-2025)
3.2 Global Multicancer Detection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Multicancer Detection Revenue
3.4 Global Multicancer Detection Market Concentration Ratio
3.4.1 Global Multicancer Detection Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Multicancer Detection Revenue in 2024
3.5 Global Key Players of Multicancer Detection Head office and Area Served
3.6 Global Key Players of Multicancer Detection, Product and Application
3.7 Global Key Players of Multicancer Detection, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Multicancer Detection Breakdown Data by Type
4.1 Global Multicancer Detection Historic Market Size by Type (2020-2025)
4.2 Global Multicancer Detection Forecasted Market Size by Type (2026-2031)
5 Multicancer Detection Breakdown Data by Application
5.1 Global Multicancer Detection Historic Market Size by Application (2020-2025)
5.2 Global Multicancer Detection Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Multicancer Detection Market Size (2020-2031)
6.2 North America Multicancer Detection Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Multicancer Detection Market Size by Country (2020-2025)
6.4 North America Multicancer Detection Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Multicancer Detection Market Size (2020-2031)
7.2 Europe Multicancer Detection Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Multicancer Detection Market Size by Country (2020-2025)
7.4 Europe Multicancer Detection Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Multicancer Detection Market Size (2020-2031)
8.2 Asia-Pacific Multicancer Detection Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Multicancer Detection Market Size by Region (2020-2025)
8.4 Asia-Pacific Multicancer Detection Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Multicancer Detection Market Size (2020-2031)
9.2 Latin America Multicancer Detection Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Multicancer Detection Market Size by Country (2020-2025)
9.4 Latin America Multicancer Detection Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Multicancer Detection Market Size (2020-2031)
10.2 Middle East & Africa Multicancer Detection Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Multicancer Detection Market Size by Country (2020-2025)
10.4 Middle East & Africa Multicancer Detection Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Agilent Technologies, Inc.
11.1.1 Agilent Technologies, Inc. Company Details
11.1.2 Agilent Technologies, Inc. Business Overview
11.1.3 Agilent Technologies, Inc. Multicancer Detection Introduction
11.1.4 Agilent Technologies, Inc. Revenue in Multicancer Detection Business (2020-2025)
11.1.5 Agilent Technologies, Inc. Recent Development
11.2 Atara Biotherapeutics, Inc.
11.2.1 Atara Biotherapeutics, Inc. Company Details
11.2.2 Atara Biotherapeutics, Inc. Business Overview
11.2.3 Atara Biotherapeutics, Inc. Multicancer Detection Introduction
11.2.4 Atara Biotherapeutics, Inc. Revenue in Multicancer Detection Business (2020-2025)
11.2.5 Atara Biotherapeutics, Inc. Recent Development
11.3 Burning Rock DX
11.3.1 Burning Rock DX Company Details
11.3.2 Burning Rock DX Business Overview
11.3.3 Burning Rock DX Multicancer Detection Introduction
11.3.4 Burning Rock DX Revenue in Multicancer Detection Business (2020-2025)
11.3.5 Burning Rock DX Recent Development
11.4 Danaher Corporation
11.4.1 Danaher Corporation Company Details
11.4.2 Danaher Corporation Business Overview
11.4.3 Danaher Corporation Multicancer Detection Introduction
11.4.4 Danaher Corporation Revenue in Multicancer Detection Business (2020-2025)
11.4.5 Danaher Corporation Recent Development
11.5 Exact Sciences Corporation
11.5.1 Exact Sciences Corporation Company Details
11.5.2 Exact Sciences Corporation Business Overview
11.5.3 Exact Sciences Corporation Multicancer Detection Introduction
11.5.4 Exact Sciences Corporation Revenue in Multicancer Detection Business (2020-2025)
11.5.5 Exact Sciences Corporation Recent Development
11.6 Hoffmann-La Roche Ltd
11.6.1 Hoffmann-La Roche Ltd Company Details
11.6.2 Hoffmann-La Roche Ltd Business Overview
11.6.3 Hoffmann-La Roche Ltd Multicancer Detection Introduction
11.6.4 Hoffmann-La Roche Ltd Revenue in Multicancer Detection Business (2020-2025)
11.6.5 Hoffmann-La Roche Ltd Recent Development
11.7 Fulgent Genetics.
11.7.1 Fulgent Genetics. Company Details
11.7.2 Fulgent Genetics. Business Overview
11.7.3 Fulgent Genetics. Multicancer Detection Introduction
11.7.4 Fulgent Genetics. Revenue in Multicancer Detection Business (2020-2025)
11.7.5 Fulgent Genetics. Recent Development
11.8 Genecast Biotechnology Co., Ltd
11.8.1 Genecast Biotechnology Co., Ltd Company Details
11.8.2 Genecast Biotechnology Co., Ltd Business Overview
11.8.3 Genecast Biotechnology Co., Ltd Multicancer Detection Introduction
11.8.4 Genecast Biotechnology Co., Ltd Revenue in Multicancer Detection Business (2020-2025)
11.8.5 Genecast Biotechnology Co., Ltd Recent Development
11.9 Guardant Health, Inc.
11.9.1 Guardant Health, Inc. Company Details
11.9.2 Guardant Health, Inc. Business Overview
11.9.3 Guardant Health, Inc. Multicancer Detection Introduction
11.9.4 Guardant Health, Inc. Revenue in Multicancer Detection Business (2020-2025)
11.9.5 Guardant Health, Inc. Recent Development
11.10 Illumina, Inc.
11.10.1 Illumina, Inc. Company Details
11.10.2 Illumina, Inc. Business Overview
11.10.3 Illumina, Inc. Multicancer Detection Introduction
11.10.4 Illumina, Inc. Revenue in Multicancer Detection Business (2020-2025)
11.10.5 Illumina, Inc. Recent Development
11.11 Konica Minolta, Inc.
11.11.1 Konica Minolta, Inc. Company Details
11.11.2 Konica Minolta, Inc. Business Overview
11.11.3 Konica Minolta, Inc. Multicancer Detection Introduction
11.11.4 Konica Minolta, Inc. Revenue in Multicancer Detection Business (2020-2025)
11.11.5 Konica Minolta, Inc. Recent Development
11.12 Laboratory Corporation of America Holdings.
11.12.1 Laboratory Corporation of America Holdings. Company Details
11.12.2 Laboratory Corporation of America Holdings. Business Overview
11.12.3 Laboratory Corporation of America Holdings. Multicancer Detection Introduction
11.12.4 Laboratory Corporation of America Holdings. Revenue in Multicancer Detection Business (2020-2025)
11.12.5 Laboratory Corporation of America Holdings. Recent Development
11.13 Myriad Genetics, Inc.
11.13.1 Myriad Genetics, Inc. Company Details
11.13.2 Myriad Genetics, Inc. Business Overview
11.13.3 Myriad Genetics, Inc. Multicancer Detection Introduction
11.13.4 Myriad Genetics, Inc. Revenue in Multicancer Detection Business (2020-2025)
11.13.5 Myriad Genetics, Inc. Recent Development
11.14 Tempus
11.14.1 Tempus Company Details
11.14.2 Tempus Business Overview
11.14.3 Tempus Multicancer Detection Introduction
11.14.4 Tempus Revenue in Multicancer Detection Business (2020-2025)
11.14.5 Tempus Recent Development
11.15 Thermo Fisher Scientific Inc.
11.15.1 Thermo Fisher Scientific Inc. Company Details
11.15.2 Thermo Fisher Scientific Inc. Business Overview
11.15.3 Thermo Fisher Scientific Inc. Multicancer Detection Introduction
11.15.4 Thermo Fisher Scientific Inc. Revenue in Multicancer Detection Business (2020-2025)
11.15.5 Thermo Fisher Scientific Inc. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global Multicancer Detection Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Laboratory Developed Tests (LDTs)
 Table 3. Key Players of In-Vitro Diagnostics (IVDs)
 Table 4. Global Multicancer Detection Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 5. Global Multicancer Detection Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global Multicancer Detection Market Size by Region (2020-2025) & (US$ Million)
 Table 7. Global Multicancer Detection Market Share by Region (2020-2025)
 Table 8. Global Multicancer Detection Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 9. Global Multicancer Detection Market Share by Region (2026-2031)
 Table 10. Multicancer Detection Market Trends
 Table 11. Multicancer Detection Market Drivers
 Table 12. Multicancer Detection Market Challenges
 Table 13. Multicancer Detection Market Restraints
 Table 14. Global Multicancer Detection Revenue by Players (2020-2025) & (US$ Million)
 Table 15. Global Multicancer Detection Market Share by Players (2020-2025)
 Table 16. Global Top Multicancer Detection Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Multicancer Detection as of 2024)
 Table 17. Ranking of Global Top Multicancer Detection Companies by Revenue (US$ Million) in 2024
 Table 18. Global 5 Largest Players Market Share by Multicancer Detection Revenue (CR5 and HHI) & (2020-2025)
 Table 19. Global Key Players of Multicancer Detection, Headquarters and Area Served
 Table 20. Global Key Players of Multicancer Detection, Product and Application
 Table 21. Global Key Players of Multicancer Detection, Date of Enter into This Industry
 Table 22. Mergers & Acquisitions, Expansion Plans
 Table 23. Global Multicancer Detection Market Size by Type (2020-2025) & (US$ Million)
 Table 24. Global Multicancer Detection Revenue Market Share by Type (2020-2025)
 Table 25. Global Multicancer Detection Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 26. Global Multicancer Detection Revenue Market Share by Type (2026-2031)
 Table 27. Global Multicancer Detection Market Size by Application (2020-2025) & (US$ Million)
 Table 28. Global Multicancer Detection Revenue Market Share by Application (2020-2025)
 Table 29. Global Multicancer Detection Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 30. Global Multicancer Detection Revenue Market Share by Application (2026-2031)
 Table 31. North America Multicancer Detection Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 32. North America Multicancer Detection Market Size by Country (2020-2025) & (US$ Million)
 Table 33. North America Multicancer Detection Market Size by Country (2026-2031) & (US$ Million)
 Table 34. Europe Multicancer Detection Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 35. Europe Multicancer Detection Market Size by Country (2020-2025) & (US$ Million)
 Table 36. Europe Multicancer Detection Market Size by Country (2026-2031) & (US$ Million)
 Table 37. Asia-Pacific Multicancer Detection Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 38. Asia-Pacific Multicancer Detection Market Size by Region (2020-2025) & (US$ Million)
 Table 39. Asia-Pacific Multicancer Detection Market Size by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Multicancer Detection Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 41. Latin America Multicancer Detection Market Size by Country (2020-2025) & (US$ Million)
 Table 42. Latin America Multicancer Detection Market Size by Country (2026-2031) & (US$ Million)
 Table 43. Middle East & Africa Multicancer Detection Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 44. Middle East & Africa Multicancer Detection Market Size by Country (2020-2025) & (US$ Million)
 Table 45. Middle East & Africa Multicancer Detection Market Size by Country (2026-2031) & (US$ Million)
 Table 46. Agilent Technologies, Inc. Company Details
 Table 47. Agilent Technologies, Inc. Business Overview
 Table 48. Agilent Technologies, Inc. Multicancer Detection Product
 Table 49. Agilent Technologies, Inc. Revenue in Multicancer Detection Business (2020-2025) & (US$ Million)
 Table 50. Agilent Technologies, Inc. Recent Development
 Table 51. Atara Biotherapeutics, Inc. Company Details
 Table 52. Atara Biotherapeutics, Inc. Business Overview
 Table 53. Atara Biotherapeutics, Inc. Multicancer Detection Product
 Table 54. Atara Biotherapeutics, Inc. Revenue in Multicancer Detection Business (2020-2025) & (US$ Million)
 Table 55. Atara Biotherapeutics, Inc. Recent Development
 Table 56. Burning Rock DX Company Details
 Table 57. Burning Rock DX Business Overview
 Table 58. Burning Rock DX Multicancer Detection Product
 Table 59. Burning Rock DX Revenue in Multicancer Detection Business (2020-2025) & (US$ Million)
 Table 60. Burning Rock DX Recent Development
 Table 61. Danaher Corporation Company Details
 Table 62. Danaher Corporation Business Overview
 Table 63. Danaher Corporation Multicancer Detection Product
 Table 64. Danaher Corporation Revenue in Multicancer Detection Business (2020-2025) & (US$ Million)
 Table 65. Danaher Corporation Recent Development
 Table 66. Exact Sciences Corporation Company Details
 Table 67. Exact Sciences Corporation Business Overview
 Table 68. Exact Sciences Corporation Multicancer Detection Product
 Table 69. Exact Sciences Corporation Revenue in Multicancer Detection Business (2020-2025) & (US$ Million)
 Table 70. Exact Sciences Corporation Recent Development
 Table 71. Hoffmann-La Roche Ltd Company Details
 Table 72. Hoffmann-La Roche Ltd Business Overview
 Table 73. Hoffmann-La Roche Ltd Multicancer Detection Product
 Table 74. Hoffmann-La Roche Ltd Revenue in Multicancer Detection Business (2020-2025) & (US$ Million)
 Table 75. Hoffmann-La Roche Ltd Recent Development
 Table 76. Fulgent Genetics. Company Details
 Table 77. Fulgent Genetics. Business Overview
 Table 78. Fulgent Genetics. Multicancer Detection Product
 Table 79. Fulgent Genetics. Revenue in Multicancer Detection Business (2020-2025) & (US$ Million)
 Table 80. Fulgent Genetics. Recent Development
 Table 81. Genecast Biotechnology Co., Ltd Company Details
 Table 82. Genecast Biotechnology Co., Ltd Business Overview
 Table 83. Genecast Biotechnology Co., Ltd Multicancer Detection Product
 Table 84. Genecast Biotechnology Co., Ltd Revenue in Multicancer Detection Business (2020-2025) & (US$ Million)
 Table 85. Genecast Biotechnology Co., Ltd Recent Development
 Table 86. Guardant Health, Inc. Company Details
 Table 87. Guardant Health, Inc. Business Overview
 Table 88. Guardant Health, Inc. Multicancer Detection Product
 Table 89. Guardant Health, Inc. Revenue in Multicancer Detection Business (2020-2025) & (US$ Million)
 Table 90. Guardant Health, Inc. Recent Development
 Table 91. Illumina, Inc. Company Details
 Table 92. Illumina, Inc. Business Overview
 Table 93. Illumina, Inc. Multicancer Detection Product
 Table 94. Illumina, Inc. Revenue in Multicancer Detection Business (2020-2025) & (US$ Million)
 Table 95. Illumina, Inc. Recent Development
 Table 96. Konica Minolta, Inc. Company Details
 Table 97. Konica Minolta, Inc. Business Overview
 Table 98. Konica Minolta, Inc. Multicancer Detection Product
 Table 99. Konica Minolta, Inc. Revenue in Multicancer Detection Business (2020-2025) & (US$ Million)
 Table 100. Konica Minolta, Inc. Recent Development
 Table 101. Laboratory Corporation of America Holdings. Company Details
 Table 102. Laboratory Corporation of America Holdings. Business Overview
 Table 103. Laboratory Corporation of America Holdings. Multicancer Detection Product
 Table 104. Laboratory Corporation of America Holdings. Revenue in Multicancer Detection Business (2020-2025) & (US$ Million)
 Table 105. Laboratory Corporation of America Holdings. Recent Development
 Table 106. Myriad Genetics, Inc. Company Details
 Table 107. Myriad Genetics, Inc. Business Overview
 Table 108. Myriad Genetics, Inc. Multicancer Detection Product
 Table 109. Myriad Genetics, Inc. Revenue in Multicancer Detection Business (2020-2025) & (US$ Million)
 Table 110. Myriad Genetics, Inc. Recent Development
 Table 111. Tempus Company Details
 Table 112. Tempus Business Overview
 Table 113. Tempus Multicancer Detection Product
 Table 114. Tempus Revenue in Multicancer Detection Business (2020-2025) & (US$ Million)
 Table 115. Tempus Recent Development
 Table 116. Thermo Fisher Scientific Inc. Company Details
 Table 117. Thermo Fisher Scientific Inc. Business Overview
 Table 118. Thermo Fisher Scientific Inc. Multicancer Detection Product
 Table 119. Thermo Fisher Scientific Inc. Revenue in Multicancer Detection Business (2020-2025) & (US$ Million)
 Table 120. Thermo Fisher Scientific Inc. Recent Development
 Table 121. Research Programs/Design for This Report
 Table 122. Key Data Information from Secondary Sources
 Table 123. Key Data Information from Primary Sources
 Table 124. Authors List of This Report


List of Figures
 Figure 1. Multicancer Detection Picture
 Figure 2. Global Multicancer Detection Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Multicancer Detection Market Share by Type: 2024 VS 2031
 Figure 4. Laboratory Developed Tests (LDTs) Features
 Figure 5. In-Vitro Diagnostics (IVDs) Features
 Figure 6. Global Multicancer Detection Market Size by Application (2020-2031) & (US$ Million)
 Figure 7. Global Multicancer Detection Market Share by Application: 2024 VS 2031
 Figure 8. Hospital Case Studies
 Figure 9. Clinic Case Studies
 Figure 10. Multicancer Detection Report Years Considered
 Figure 11. Global Multicancer Detection Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 12. Global Multicancer Detection Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 13. Global Multicancer Detection Market Share by Region: 2024 VS 2031
 Figure 14. Global Multicancer Detection Market Share by Players in 2024
 Figure 15. Global Top Multicancer Detection Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Multicancer Detection as of 2024)
 Figure 16. The Top 10 and 5 Players Market Share by Multicancer Detection Revenue in 2024
 Figure 17. North America Multicancer Detection Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 18. North America Multicancer Detection Market Share by Country (2020-2031)
 Figure 19. United States Multicancer Detection Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 20. Canada Multicancer Detection Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 21. Europe Multicancer Detection Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. Europe Multicancer Detection Market Share by Country (2020-2031)
 Figure 23. Germany Multicancer Detection Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. France Multicancer Detection Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. U.K. Multicancer Detection Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. Italy Multicancer Detection Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. Russia Multicancer Detection Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Nordic Countries Multicancer Detection Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Asia-Pacific Multicancer Detection Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Asia-Pacific Multicancer Detection Market Share by Region (2020-2031)
 Figure 31. China Multicancer Detection Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Japan Multicancer Detection Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. South Korea Multicancer Detection Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Southeast Asia Multicancer Detection Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. India Multicancer Detection Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Australia Multicancer Detection Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Latin America Multicancer Detection Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Latin America Multicancer Detection Market Share by Country (2020-2031)
 Figure 39. Mexico Multicancer Detection Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Brazil Multicancer Detection Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Middle East & Africa Multicancer Detection Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Middle East & Africa Multicancer Detection Market Share by Country (2020-2031)
 Figure 43. Turkey Multicancer Detection Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Saudi Arabia Multicancer Detection Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. UAE Multicancer Detection Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Agilent Technologies, Inc. Revenue Growth Rate in Multicancer Detection Business (2020-2025)
 Figure 47. Atara Biotherapeutics, Inc. Revenue Growth Rate in Multicancer Detection Business (2020-2025)
 Figure 48. Burning Rock DX Revenue Growth Rate in Multicancer Detection Business (2020-2025)
 Figure 49. Danaher Corporation Revenue Growth Rate in Multicancer Detection Business (2020-2025)
 Figure 50. Exact Sciences Corporation Revenue Growth Rate in Multicancer Detection Business (2020-2025)
 Figure 51. Hoffmann-La Roche Ltd Revenue Growth Rate in Multicancer Detection Business (2020-2025)
 Figure 52. Fulgent Genetics. Revenue Growth Rate in Multicancer Detection Business (2020-2025)
 Figure 53. Genecast Biotechnology Co., Ltd Revenue Growth Rate in Multicancer Detection Business (2020-2025)
 Figure 54. Guardant Health, Inc. Revenue Growth Rate in Multicancer Detection Business (2020-2025)
 Figure 55. Illumina, Inc. Revenue Growth Rate in Multicancer Detection Business (2020-2025)
 Figure 56. Konica Minolta, Inc. Revenue Growth Rate in Multicancer Detection Business (2020-2025)
 Figure 57. Laboratory Corporation of America Holdings. Revenue Growth Rate in Multicancer Detection Business (2020-2025)
 Figure 58. Myriad Genetics, Inc. Revenue Growth Rate in Multicancer Detection Business (2020-2025)
 Figure 59. Tempus Revenue Growth Rate in Multicancer Detection Business (2020-2025)
 Figure 60. Thermo Fisher Scientific Inc. Revenue Growth Rate in Multicancer Detection Business (2020-2025)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

SIS Group of Schools

SIMILAR REPORTS

RELATED REPORTS

Global Pharma and Healthcare Social Media Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-14Y6812
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Food Additives Testing Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-34O3983
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Gabapentin API Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-9V17601
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Informed Consent Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-22C17047
Fri Sep 12 00:00:00 UTC 2025

Add to Cart